Doha :  The Population Health & Wellbeing Series was launched to explore how evidence-based integrative and preventive approaches can promote health and tackle various public health problems, ranging from infectious diseases like COVID-19 and hepatitis C, to lifestyle-related non-communicable diseases such as type 2 diabetes, obesity, and metabolic syndrome.

Since the series was launched, a total of 12 webinars have been hosted by the IPH, each presented by a different expert speaker. Recent topics have included social determinants of non-communicable diseases in the Eastern Mediterranean Region, presented by Dr. Hanan Abdul Rahim of Qatar University; the role of lifestyle in medicine in population health by Dr. James Rippe of the University of Massachusetts Medical School; the experience of WCM-Q in optimizing public health research during the COVID-19 pandemic by Dr. Sohaila Cheema of WCM-Q; and the use of big data in population health research related to hepatitis C and COVID-19 by Dr. Adeel Butt of Hamad Medical Corporation and WCM-Q. One of the highlights of the series was a presentation titled ‘Battling the COVID-19 pandemic: A perspective from Qatar’ by Dr. Mohamed Bin Hamad Bin Jassim Al-Thani, Director of the Public Health Department at the Ministry of Public Health, Qatar and Associate Professor of Population Health Sciences at WCM-Q and Qatar University.

Dr. Ravinder Mamtani, Professor of Population Health Sciences/Professor of Medicine (Center for Global Health) and Vice Dean for Population Health and Lifestyle Medicine

at WCM-Q said: “We are extremely grateful to the highly esteemed Dr. Mohamed Bin Hamad Bin Jassim Al-Thani of the Ministry of Public Health for giving us the benefit of his expertise and insights into the excellent work that has been done in Qatar to contain the COVID-19 pandemic, which has undoubtedly saved a great many lives. Thanks to the high caliber of our expert speakers and the excellence of their presentations, I am happy to say that our Population Health & Wellbeing Series has been a tremendous success and is going from strength to strength.”

Other topics addressed by the series include a New York perspective of professional medical conduct, presented by Paula M. Breen of the New York State Department of Health; lessons from four decades of experience in medical education, by Dr. William W. Pinsky of the Educational Commission for Foreign Medical Graduates; strategies for integrating real-world data with clinical trial data to improve decision-making, presented by Dr. Ronac Mamtani and Dr. Rebecca Hubbard, both of the University of Pennsylvania; and ‘The Living Gap: Bridged by Compassion’ presented by Dr. David Reilly, Director of TheWEL Programmes and The Healing Shift Enquiry.

-Ends- 

About Weill Cornell Medicine - Qatar 

Weill Cornell Medicine - Qatar is a partnership between Cornell University and Qatar Foundation. It offers a comprehensive six-year medical program leading to the Cornell University M.D. degree with teaching by Cornell and Weill Cornell faculty and by physicians at Hamad Medical Corporation (HMC), Aspetar Orthopedic and Sports Medicine Hospital, the Primary Health Care Corporation, the Feto Maternal Center, and Sidra Medicine, who hold Weill Cornell appointments. Through its biomedical research program, WCM-Q is building a sustainable research community in Qatar while advancing basic science and clinical research. Through its medical college, WCM-Q seeks to provide the finest education possible for medical students, to improve health care both now and for future generations, and to provide high quality health care to the Qatari population.

For more info, please contact:
Hanan Lakkis
Associate Director, Media and Publications
Weill Cornell Medicine - Qatar
hyl2004@qatar-med.cornell.edu 

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2022

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.